New research using high-resolution imaging reveals how polymyxin B, a last-resort antibiotic, kills bacteria by inducing energy-dependent disruption of the bacterial outer membrane. The study found that the antibiotic's efficacy depends on bacterial metabolic activity, with dormant cells evading killing due to reduced membrane remodeling. This explanation for antibiotic resistance in dormant bacteria offers critical insight into recurring infections and potential strategies to enhance treatment effectiveness.